نتایج جستجو برای: myeloablative conditioning

تعداد نتایج: 48131  

Journal: :Blood 2005
Edwin P Alyea Haesook T Kim Vincent Ho Corey Cutler John Gribben Daniel J DeAngelo Stephanie J Lee Sarah Windawi Jerome Ritz Richard M Stone Joseph H Antin Robert J Soiffer

Nonmyeloablative stem cell transplantation (NST) is increasingly used in older patients. The impact of the shift from myeloablative transplantation to NST on relapse, transplant complications, and outcome has yet to be fully examined. We performed a retrospective analysis of 152 patients older than 50 years undergoing NST or myeloablative transplantation. Seventy-one patients received nonmyeloa...

Journal: :Haematologica 2000
A M Carella S Giralt S Slavin

Conventional myeloablative conditioning regimens for allografting rely on the use of toxic myeloablative and immunosuppressive therapies to achieve engraftment and control of hematologic neoplasias. Unfortunately, these regimens have resulted in substantial morbidity and mortality. Preclinical and pilot clinical studies have shown that conditioning regimens can be reduced in intensity (resultin...

Journal: :Critical reviews in oncology/hematology 2007
Michael Y Shapira P Tsirigotis I B Resnick R Or A Abdul-Hai S Slavin

The development of reduced intensity or non-myeloablative conditioning (NST) in preparation for allogeneic stem cell transplantation (SCT) revolutionized the field and led to reconsideration of the dogma of upper age limit that was set up by the transplant centers as an eligibility parameter. Analysis of the literature data showed that NST regimens are associated with decreased transplant relat...

2003
Takahiro Fukuda Michael Boeckh Rachel A. Carter Brenda M. Sandmaier Michael B. Maris David G. Maloney Paul J. Martin Rainer F. Storb Kieren A. Marr

The incidence of invasive mold infections has increased during the 1990s among patients undergoing allogeneic hematopoietic stem cell transplantation (HCT) after myeloablative conditioning. In this study, we determined risk factors for invasive mold infection and mold infectionrelated death among 163 patients undergoing allogeneic HCT with nonmyeloablative conditioning. The cumulative incidence...

Journal: :Haematologica 2011
Ron Ram Rainer Storb Brenda M Sandmaier David G Maloney Ann Woolfrey Mary E D Flowers Michael B Maris Ginna G Laport Thomas R Chauncey Thoralf Lange Amelia A Langston Barry Storer George E Georges

BACKGROUND Allogeneic hematopoietic cell transplantation is a potentially curative treatment for patients with acute lymphoblastic leukemia. However, the majority of older adults with acute lymphoblastic leukemia are not candidates for myeloablative conditioning regimens. A non-myeloablative preparative regimen is a reasonable treatment option for this group. We sought to determine the outcome ...

Journal: :Haematologica 2011
Josep-Maria Ribera

A llogeneic hematopoietic stem cell transplantation (HSCT) with a myeloablative conditioning regi-men is considered the most potent post-remission antileukemic therapy in adult acute lymphoblastic leukemia (ALL). 1,2 However, an adequate balance should be established between its curative potential, the disadvantages (transplant-related mortality, late complications and reduced quality of life) ...

Journal: :Haematologica 2014
Myriam Labopin Annalisa Ruggeri Norbert Claude Gorin Eliane Gluckman Didier Blaise Lionel Mannone Noel Milpied Ibrahim Yakoub-Agha Eric Deconinck Mauricette Michallet Nathalie Fegueux Gerard Socié Stephanie Nguyen Jean Yves Cahn Thierry de Revel Federico Garnier Catherine Faucher Namik Taright Chantal Kenzey Fernanda Volt Dominique Bertrand Mohamad Mohty Vanderson Rocha

Double cord blood transplantation extends the use of cord blood to adults for whom a single unit is not available, but the procedure is limited by its cost. To evaluate outcomes and cost-effectiveness of double compared to single cord blood transplantation, we analyzed 134 transplants in adults with acute leukemia in first remission. Transplants were performed in France with reduced intensity o...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008
Anna Sureda Stephen Robinson Carmen Canals Angelo M Carella Marc A Boogaerts Dolores Caballero Ann E Hunter Lothar Kanz Shimon Slavin Jan J Cornelissen Martin Gramatzki Dietger Niederwieser Nigel H Russell Norbert Schmitz

PURPOSE To compare the clinical outcome in terms of nonrelapse mortality (NRM), relapse rate (RR), overall survival (OS), and progression-free survival (PFS) in patients with relapsed Hodgkin's lymphoma (HL) treated with reduced-intensity conditioning (RIC) or myeloablative conditioning followed by allogeneic stem-cell transplantation (alloSCT). PATIENTS AND METHODS A total of 168 patients wi...

Journal: :The Netherlands journal of medicine 2005
T E Buffart J J W M Janssen P C Huijgens

Allogeneic stem cell transplantation is a potentially curative procedure for patients with haematological malignancies. Conventional, myeloablative conditioning is, however, poorly tolerated by patients of advanced age, those receiving second transplants and those with concomitant diseases. Based on recognition of the importance of a graft-versus-disease (GVD) effect in curing malignant haemato...

Journal: :Haematologica 2011
Hirohisa Nakamae Barry Storer Brenda M Sandmaier David G Maloney Chris Davis Lawrence Corey Rainer Storb Michael Boeckh

BACKGROUND Secondary cytopenias are serious complications following hematopoietic cell transplantation. Etiologies include myelotoxic agents, viral infections, and possibly transplant-related factors such as the intensity of the conditioning regimen and the source of stem cells. DESIGN AND METHODS We retrospectively analyzed data from 2162 hematopoietic cell transplant recipients to examine t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید